Trial reportJMIR mHealth and uHealth2025
Smartphone-Based Approach-Avoidance Bias Modification Training for Depression: Randomized Clinical Trial.
Trial report in JMIR mHealth and uHealth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Effective treatments for depression are available, yet many patients do not respond to treatment or experience relapse. Cognitive bias modification aims to ameliorate cognitive biases that contribute to the development and maintenance of the disorder. Objective: This study examines the efficacy of a novel mobile approach-avoidance bias modification training with socioemotional cues for depression. Methods: In this randomized clinical superiority trial, 75 inpatients with depression underwent 6 sessions of either active or sham approach-avoidance bias modification training with socioemotional cues over the course of 2 weeks alongside inpatient treatment as usual. The primary outcome was self-reported depressive symptoms, and the secondary outcomes included approach-avoidance bias based on reaction time and response force, anhedonia, and positivity. Outcomes were assessed before and after the training, and again at 2-week and 6-month follow-ups. The primary hypothesis was that active training would lead to a stronger decrease in symptoms of depression at the end of training. Results: Both groups improved in depressive symptoms from baseline to the end-of-training assessment but did not differ in this regard (B=-1.14, 95% CI -5.65-3.41; t188.61=-0.47; P=.64; d=-0.09, 95% CI -0.46-0.28). Changes in anhedonia, positivity, and approach-avoidance bias were also not different between training groups, neither at end of training (P=.16) nor at the 2-week follow-up (P=.69). However, the active training group showed a significantly greater reduction in depressive symptoms from the baseline assessment to the 6-month follow-up (B=7.26, 95% CI 2.53-11.93; t190.54=2.95; P=.004; d=0.58, 95% CI 0.20-0.96). Permuted split-half reliability of the mobile assessment of approach-avoidance bias ranged from 0.77 to 0.94 for reaction times and from 0.81 to 0.93 for response force. Approach-avoidance bias was not altered by the training and did not mediate the training effects. Conclusions: Mobile approach-avoidance bias modification training with socioemotional cues did not reduce depressive symptoms in the short term but did in the long term. Mobile training and assessment versions may be more feasible in the future, as they require no joystick setup and can be conducted on patients' smartphones. Future work needs to further examine short- and long-term efficacy and the mechanisms driving long-term symptom change in larger multicenter trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.